ENTITY

SpyGlass Pharma (SGP US)

9
Analysis
Health Care • United States
Spyglass Pharma, Inc. operates as an ophthalmic biotechnology company. The company provides drug delivery platform, lasting treatment, and routine ophthalmic surgery. Spyglass Pharma serves glaucoma patients worldwide.
more
Exchange Announcement • 01 Oct 2026 20:15

Current Report (Form 8-K | Period ending 2026-10-01)

Exchange Announcement • 07 Aug 2026 04:16

Current Report (Form 8-K | Period ending 2026-08-06)

Exchange Announcement • 06 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 15 May 2026 04:15

Current Report (Form 8-K | Period ending 2026-05-14)

Exchange Announcement • 14 May 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

x